+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Multi system stem cell failure following apparent recovery from alkylating agents



Multi system stem cell failure following apparent recovery from alkylating agents



Proceedings of the American Association for Cancer Research 18: 121




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 026999876

Download citation: RISBibTeXText


Related references

Multi system stem cell failure after apparent recovery from alkylating agents. Cancer Research 38(7): 1942-1947, 1978

Multi system stem cell following apparent recovery from alkylating agents. Radiation Research 70(3): 662, 1977

Multiple organ failure presumably due to alkylating agents used as preconditioning drugs for autologous peripheral blood stem cell transplantation in an acute promyelocytic leukemia. Japanese Journal of Clinical Hematology 57(1): 41-46, 2016

Comparisons of the biological effects of ionizing radiations and certain alkylating agents in cell system. In: Comparative clinical and biological effects of alkylating agents. Ann New York Acad Sci 68(3): 702-720, 1958

Transfection of murine multi-potent haemopoietic stem cells with an E. coli DNA alkyltransferase gene confers resistance to the toxic effects of alkylating agents. Carcinogenesis 9(1): 81-87, 1988

Cell survival recovery kinetics in the KHT sarcoma following treatment with five alkylating agents and misonidazole. International Journal of Radiation Oncology Biology Physics 8(3-4): 619-622, 1982

Cell survival recovery kinetics in the kht sarcoma following treatment with 5 alkylating agents and misonidazole. International Journal Of Radiation Oncology, Biology, Physics: 619-622, 1982

Multi-institutional phase II, randomized dose finding study of defibrotide in patients with severe veno-occlusive disease and multi-system organ failure post stem cell transplantation Promising response rate without significant toxicity in a high risk population. Blood 98(11 Part 1): 853a, 2001

Failure of alkylating agents to improve induction chemotherapy of oropharyngeal squamous cell cancer. Anticancer Research 24(4): 2557-2561, 2004

Genomic phenotyping by barcode sequencing broadly distinguishes between alkylating agents, oxidizing agents, and non-genotoxic agents, and reveals a role for aromatic amino acids in cellular recovery after quinone exposure. Plos one 8(9): E73736, 2013

Transcriptional blockages in a cell-free system by sequence-selective DNA alkylating agents. Chemico-Biological Interactions 126(1): 15-31, 2000

Defibrotide is effective in the treatment of severe veno-occlusive disease and multi-system organ failure post stem cell transplantation Results of a phase II, multicenter, randomized Study. Blood 102(11): 193a, 2003

Defibrotide Appears Effective and Safe in a Phase II, Randomized Study of Patients with Severe Veno-Occlusive Disease and Multi-System Organ Failure Post Stem Cell Transplantation. Blood 100(11): Abstract No 414, 2002

Donor peripheral stem cells infusion for the treatment of failure of platelet recovery after allogeneic hematopoietic stem cell transplantation. Zhonghua Yi Xue Za Zhi 87(14): 964-966, 2007